<DOC>
	<DOC>NCT01187849</DOC>
	<brief_summary>The purpose of this study is to evaluate if a treatment with metformin compared to placebo reduces metabolic side-effects in patients with glucocorticoid treatment over three months time.</brief_summary>
	<brief_title>Metformin to Prevent Metabolic Complications in Glucocorticoid Excess</brief_title>
	<detailed_description />
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Glucocorticoids</mesh_term>
	<criteria>Glucocorticoid treatment for ≥ 3 months with a prednisone dose of ≥ 7.5mg/d or equivalent glucocorticoid Refusal of informed consent Prior therapy with metformin during the last 6 month Preexisting diabetes Pregnancy or current malignancy Renal insufficiency with a creatinine clearance lower than 30ml/min</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>